Catalyst Wire Dossier Catalyst Wire Dossier

Epigallocatechin-3-gallate (EGCG)

Epigallocatechin-3-gallate
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Epigallocatechin-3-gallate (EGCG), covering 2017-10-17 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients [Phase 1]

See pricing